Top Markets
#1 Islamic Coin Islamic Coin +151.46%
#2 DOVU DOVU +50.32%
#3 Velvet Velvet +36.95%
#4 Black Phoenix Black Phoenix +34.87%
#5 Akedo Akedo +23.18%
#6 Fake World Assets Fake World Assets +21.86%
#7 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +19.21%
#8 DoubleZero DoubleZero +16.03%
#9 Palladium Network Palladium Network +15.82%
#10 HOME HOME +11.51%
Coin of the day
Islamic Coin Islamic Coin
Einstellungen
Sprache
DEUTSCH
Währung
USD
Thema
Biocure Technology Inc. Biocure Technology Inc.

Biocure Technology Inc.

CURE
Rang in Aktien #39914
Biocure Technology Inc., operating with its subsidiary, focuses on the creation... Biocure Technology Inc., operating with its subsidiary, focuses on the creation and market introduction of biopharmaceutical innovations, particularly those involving recombinant technologies and ranibizumab. The company's current development pipeline includes: Interferons-ß, aimed at treating multiple sclerosis. Ranibizumab, a monoclonal antibody fragment designed to address macular degeneration and a related eye condition known as macular edema. Filgrastim, which targets neutropenia – a deficiency of white blood cells that can arise from cancer, bone marrow transplants, chemotherapy, or other medical issues. Additionally, Biocure is conducting research and development into several promising areas: CAR T-cell therapy, which works by identifying and eradicating cancer cells. A vaccine against foot and mouth disease. Various products for promoting hair growth. The firm was established in 2005 and its corporate headquarters are located in Vancouver, Canada.
Aktienkurs
$0.00366968
Zuletzt synchronisiert: 2024-07-12
Marktkapitalisierung
$299.46K
Veränderung (1 Tag)
-66.77%
Veränderung (1 Jahr)
0.00%
Land
CA
Handel Biocure Technology Inc. (CURE)

Kategorie

Healthcare
Aktien-Split-Historie für Biocure Technology Inc. (CURE)
Die Aktie Biocure Technology Inc. (Symbol: CURE) durchlief insgesamt 0 Aktiensplits.
Der letzte Aktiensplit fand am Aug 14, 2026 statt.
Eine CURE-Aktie, die vor dem Aug 14, 2026 gekauft wurde, entspricht heute 0 CURE-Aktien.
Liste der Aktiensplits
Jahr Aktien-Split Multiplikator Kumulierter Multiplikator
Nicht genügend Daten für die angegebenen Daten.
Aktiensplits ähnlicher Unternehmen oder Wettbewerber
Unternehmen Anzahl der Aktiensplits Kumulierter Multiplikator Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 1 x2
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 0 -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 0 -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 0 -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 0 -
BE